Darrow M, Brammer W K, Rowley A
Transitional Residency Program, PSL Hospital, Denver, CO, USA.
Arch Phys Med Rehabil. 1995 Jul;76(7):685-7. doi: 10.1016/s0003-9993(95)80641-5.
Thyrotoxic periodic paralysis (TPP) is a disorder that affects a small percentage of patients with hyperthyroidism; the patients are predominantly Asian men. Two typical cases are presented here; both patients came to the emergency room with complaints of sudden onset of weakness. Their symptoms were initially resolved through treatment for acute hypokalemia. Additional tests identified the patients as being thyrotoxic for which condition they underwent thyroid ablation with radioiodine. No further episodes were reported for either patient. Often the underlying cause of the weakness or paralysis is undetected because of the absence of clinical symptoms of hyperthyroidism and because clinicians are unfamiliar with the disorder. It is imperative that TPP be recognized in the differential diagnosis of weakness and that the underlying thyrotoxicity is treated to permanently alleviate the condition. The authors discuss the epidemiology, etiology, clinical manifestations, and treatments of TPP.
甲状腺毒症性周期性瘫痪(TPP)是一种仅影响一小部分甲亢患者的疾病;患者主要为亚洲男性。本文介绍了两例典型病例;两名患者均因突发无力前来急诊室就诊。他们的症状最初通过急性低钾血症的治疗得到缓解。进一步检查确定患者为甲状腺毒症,为此他们接受了放射性碘甲状腺消融治疗。两名患者均未再出现发作情况。由于缺乏甲亢的临床症状且临床医生对该疾病不熟悉,无力或瘫痪的潜在病因常常未被发现。在对无力进行鉴别诊断时必须认识到TPP,并治疗潜在的甲状腺毒症以永久缓解病情。作者讨论了TPP的流行病学、病因、临床表现和治疗方法。